1. Home
  2. RBC vs ICLR Comparison

RBC vs ICLR Comparison

Compare RBC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBC
  • ICLR
  • Stock Information
  • Founded
  • RBC 1919
  • ICLR 1990
  • Country
  • RBC United States
  • ICLR Ireland
  • Employees
  • RBC N/A
  • ICLR N/A
  • Industry
  • RBC Metal Fabrications
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • RBC Industrials
  • ICLR Health Care
  • Exchange
  • RBC Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • RBC 12.6B
  • ICLR 14.3B
  • IPO Year
  • RBC 2005
  • ICLR 1998
  • Fundamental
  • Price
  • RBC $432.02
  • ICLR $162.73
  • Analyst Decision
  • RBC Buy
  • ICLR Buy
  • Analyst Count
  • RBC 6
  • ICLR 15
  • Target Price
  • RBC $441.17
  • ICLR $205.07
  • AVG Volume (30 Days)
  • RBC 220.3K
  • ICLR 963.3K
  • Earning Date
  • RBC 10-31-2025
  • ICLR 10-22-2025
  • Dividend Yield
  • RBC N/A
  • ICLR N/A
  • EPS Growth
  • RBC 19.54
  • ICLR N/A
  • EPS
  • RBC 8.20
  • ICLR 7.47
  • Revenue
  • RBC $1,723,400,000.00
  • ICLR $8,102,602,000.00
  • Revenue This Year
  • RBC $14.28
  • ICLR N/A
  • Revenue Next Year
  • RBC $10.86
  • ICLR $0.89
  • P/E Ratio
  • RBC $52.69
  • ICLR $21.70
  • Revenue Growth
  • RBC 8.27
  • ICLR N/A
  • 52 Week Low
  • RBC $290.56
  • ICLR $125.10
  • 52 Week High
  • RBC $448.74
  • ICLR $228.29
  • Technical
  • Relative Strength Index (RSI)
  • RBC 63.03
  • ICLR 40.46
  • Support Level
  • RBC $422.62
  • ICLR $155.00
  • Resistance Level
  • RBC $448.74
  • ICLR $167.43
  • Average True Range (ATR)
  • RBC 12.35
  • ICLR 6.33
  • MACD
  • RBC 0.70
  • ICLR -0.64
  • Stochastic Oscillator
  • RBC 64.96
  • ICLR 30.91

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: